BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27760791)

  • 21. ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.
    Bullock M; Lim G; Zhu Y; Åberg H; Kurdyukov S; Clifton-Bligh R
    Thyroid; 2019 Nov; 29(11):1623-1633. PubMed ID: 31452441
    [No Abstract]   [Full Text] [Related]  

  • 22. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TERT Promoter Mutations in Papillary Thyroid Microcarcinomas.
    de Biase D; Gandolfi G; Ragazzi M; Eszlinger M; Sancisi V; Gugnoni M; Visani M; Pession A; Casadei G; Durante C; Costante G; Bruno R; Torlontano M; Paschke R; Filetti S; Piana S; Frasoldati A; Tallini G; Ciarrocchi A
    Thyroid; 2015 Sep; 25(9):1013-9. PubMed ID: 26148423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN promoter methylation in sporadic thyroid carcinomas.
    Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
    Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
    Labussière M; Boisselier B; Mokhtari K; Di Stefano AL; Rahimian A; Rossetto M; Ciccarino P; Saulnier O; Paterra R; Marie Y; Finocchiaro G; Sanson M
    Neurology; 2014 Sep; 83(13):1200-6. PubMed ID: 25150284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
    Fukahori M; Yoshida A; Hayashi H; Yoshihara M; Matsukuma S; Sakuma Y; Koizume S; Okamoto N; Kondo T; Masuda M; Miyagi Y
    Thyroid; 2012 Jul; 22(7):683-9. PubMed ID: 22650231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
    Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
    Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up study of patients treated by x-ray epilation for tinea capitis. Estimation of the dose to the thyroid and pituitary glands and other structures of the head and neck.
    Harley NH; Albert RE; Shore RE; Pasternack BS
    Phys Med Biol; 1976 Jul; 21(4):631-42. PubMed ID: 972927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
    Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
    Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes.
    Vinagre J; Nabais J; Pinheiro J; Batista R; Oliveira RC; Gonçalves AP; Pestana A; Reis M; Mesquita B; Pinto V; Lyra J; Cipriano MA; Ferreira MG; Lopes JM; Sobrinho-Simões M; Soares P
    Sci Rep; 2016 Jul; 6():29714. PubMed ID: 27411289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the telomerase reverse transcriptase promoter and PIK3CA gene are common events in penile squamous cell carcinoma of Italian and Ugandan patients.
    Starita N; Pezzuto F; Sarno S; Losito NS; Perdonà S; Buonaguro L; Buonaguro FM; Tornesello ML
    Int J Cancer; 2022 Jun; 150(11):1879-1888. PubMed ID: 35253909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro radiosensitivity of fibroblasts from thyroid and skin cancer patients treated with X-rays for tinea capitis.
    Ron E; Tarone RE; Modan B; Chaki R; Alfandary E; Parry DM; Makar M; Setlow N; Mulvihill JJ; Miller RW
    Cancer Epidemiol Biomarkers Prev; 1994; 3(3):229-32. PubMed ID: 8019372
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Paulsson JO; Mu N; Shabo I; Wang N; Zedenius J; Larsson C; Juhlin CC
    Endocr Relat Cancer; 2018 Jul; 25(7):723-733. PubMed ID: 29692346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
    Lemoine NR; Mayall ES; Wyllie FS; Williams ED; Goyns M; Stringer B; Wynford-Thomas D
    Oncogene; 1989 Feb; 4(2):159-64. PubMed ID: 2648253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
    Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
    Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
    Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
    J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
    Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M
    J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.